Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiamma Buttitta

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in humanFrancesco Cipollone, Maria Luigia Fazia, Annalisa Iezzi, et al.
Journal of Clinical Pathology|October 6, 2020
Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS NetworkCaterina Fumagalli, Elena Guerini-Rocco, Fiamma Buttitta, et al.
Human Mutation|February 23, 2008
Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lungAntonio Marchetti, Lara Felicioni, Giuseppe Pelosi, et al.
Stroke|August 6, 2011
A unique microRNA signature associated with plaque instability in humansFrancesco Cipollone, Lara Felicioni, Riccardo Sarzani, et al.
Plos One|August 20, 2014
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatmentAntonio Marchetti, Maela Del Grammastro, Lara Felicioni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2014
ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: results of the first italian external quality assurance schemeAntonio Marchetti, Massimo Barberis, Mauro Papotti, et al.
The EMBO Journal|June 13, 2009
MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathwayFrancesca Mancini, Giusy Di Conza, Marsha Pellegrino, et al.
Plos One|August 1, 2012
Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implicationsAntonio Marchetti, Maela Del Grammastro, Giampaolo Filice, et al.
International Journal of Cancer|September 22, 2006
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar featuresFiamma Buttitta, Fabio Barassi, Giuseppina Fresu, et al.
Pathologica|October 8, 2024
A preliminary study on the diagnostic performance of the uPath PD-L1 (SP263) artificial intelligence (AI) algorithm in patients with NSCLC treated with PD-1/PD-L1 checkpoint blockadeAlessio Cortellini, Claudia Zampacorta, Michele De Tursi, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in humanFrancesco Cipollone, Maria Luigia Fazia, Annalisa Iezzi, et al.
Journal of Clinical Pathology|October 6, 2020
Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS NetworkCaterina Fumagalli, Elena Guerini-Rocco, Fiamma Buttitta, et al.
Human Mutation|February 23, 2008
Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lungAntonio Marchetti, Lara Felicioni, Giuseppe Pelosi, et al.
Stroke|August 6, 2011
A unique microRNA signature associated with plaque instability in humansFrancesco Cipollone, Lara Felicioni, Riccardo Sarzani, et al.
Plos One|August 20, 2014
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatmentAntonio Marchetti, Maela Del Grammastro, Lara Felicioni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2014
ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: results of the first italian external quality assurance schemeAntonio Marchetti, Massimo Barberis, Mauro Papotti, et al.
The EMBO Journal|June 13, 2009
MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathwayFrancesca Mancini, Giusy Di Conza, Marsha Pellegrino, et al.
Plos One|August 1, 2012
Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implicationsAntonio Marchetti, Maela Del Grammastro, Giampaolo Filice, et al.
International Journal of Cancer|September 22, 2006
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar featuresFiamma Buttitta, Fabio Barassi, Giuseppina Fresu, et al.
Pathologica|October 8, 2024
A preliminary study on the diagnostic performance of the uPath PD-L1 (SP263) artificial intelligence (AI) algorithm in patients with NSCLC treated with PD-1/PD-L1 checkpoint blockadeAlessio Cortellini, Claudia Zampacorta, Michele De Tursi, et al.
Pageof 6